In vitro disease-modeling experiments with dex30 cells recapitulated the diabetes and CHH in the probands and suggested that dex30 does not affect the GEF activity of MADD, but induces changes in the PPIs, likely affecting multiple signaling pathways. The gene discussed is MADD; the disease is diabetes mellitus.